Specifica Inc.
Santa Fe, NM, US· latest recorded location
SPECIFICA INC. is named on 2 US grants and 5 published applications in this corpus. Its most frequent classification is C07K (Peptides).
- Granted patents
- 2
- Published applications
- 5
- Inventors
- 4
- Granted in 2026 so far
- 0
- Most recent grant
- 22 Feb 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 1 | 2 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year.
Technology areas
Share of 7 documents
Recent patents
- Antibody libraries with maximized antibody developability characteristics22 Feb 2022US 11,254,931 B2
- Antibody libraries with maximized antibody developability characteristics23 Mar 2021US 10,954,508 B2
- Single domain antibody libraries with maximized antibody developability characteristics16 Jan 2025US 2025/0020659 A1
- Anti-b7-h4 antibodies and uses thereof19 Sep 2024US 2024/0309095 A1
- Antibody libraries with maximized antibody developability characteristics15 Jul 2021US 2021/0214720 A1
- Antibody libraries with maximized antibody developability characteristics10 Jun 2021US 2021/0171936 A1
- Antibody libraries with maximized antibody developability characteristics9 Jan 2020US 2020/0010828 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.